Search
Celldex Therapeutics Inc
CLDXAdd to Watchlist
31.000USD
-0.240-0.77%
Market hours 11/10, 11:15（ET）
2.43BMarket Cap
LossP/E TTM
Today
-0.77%
5 Days
+6.75%
1 Month
+3.71%
6 Months
-8.74%
Year to Date
+14.14%
1 Year
+35.37%
Key Figures
31.150Open
31.660High
25.14KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.03%Turnover Ratio
31.240Prev. Close
29.420Low
784.85KTurnover
LossP/E Static
3.75P/B
0.00%Div Yield TTM
-45.36%ROA
45.14052wk High
0.08Volume Ratio
-157.86MNet Profit
78.53MShares
-4.2673EPS TTM
0.96Beta
-48.94%ROE
22.10052wk Low
7.17%Amplitude
100.00%Gross Margin
2.43BMarket Cap
5.91Reward/Risk
3.32%Risk Rate
More news coming soon, stay tuned...
Celldex Therapeutics Inc's Score
0.10vs previous score
Forecast8.53
Financial Health5.69
Technical3.96
Valuation Dimensions7.90
Institutional Confidence10.00
Risk Assessment5.89
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Celldex Therapeutics Inc Technical Analysis
Technical Indicators
Neutral
Summary
Neutral
Moving Average
Neutral
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.96/-1.02
Revenue / Forecast
--/707.14K
Celldex Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolCLDX
Number of employees186
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Wellington Management Company, LLP | 10.29% |
| Kynam Capital Management LP | 7.57% |
| BlackRock Institutional Trust Company, N.A. | 5.80% |
| Bellevue Asset Management AG | 4.61% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 35.54% |
| Investment Advisor/Hedge Fund | 28.62% |
| Hedge Fund | 26.50% |
| Venture Capital | 2.76% |
Related Instruments
-0.07%
-0.63%
-0.38%
-2.02%
-0.44%
-1.80%
-0.78%
-0.34%
-2.34%
-0.84%
-1.07%
-0.93%
+0.96%
-0.45%
-0.66%
-4.55%
-1.07%
-1.56%
+0.03%
+0.17%Popular Instruments
52038.700
-359.400 (-0.69%)
27724.700
-191.900 (-0.69%)
7501.200
-50.100 (-0.66%)
12797.000
-1.000 (-0.01%)
60251.000
-593.000 (-0.97%)
6346.200
+17.700 (+0.28%)
85.178
-1.124 (-1.30%)
347.300
-3.390 (-0.97%)
169.880
-8.790 (-4.92%)
4038.310
-103.180 (-2.49%)
FAQs
What is the current price of Celldex Therapeutics Inc (CLDX)?
The current price of Celldex Therapeutics Inc (CLDX) is 31.24.
What is the symbol of Celldex Therapeutics Inc?
The ticker symbol of Celldex Therapeutics Inc is CLDX.
What is the 52-week high of Celldex Therapeutics Inc?
The 52-week high of Celldex Therapeutics Inc is 45.14.
What is the 52-week low of Celldex Therapeutics Inc?
The 52-week low of Celldex Therapeutics Inc is 22.10.
What is the market capitalization of Celldex Therapeutics Inc?
The market capitalization of Celldex Therapeutics Inc is 2.45B.
Is Celldex Therapeutics Inc (CLDX) currently rated as Buy, Hold, or Sell?
According to analysts, Celldex Therapeutics Inc (CLDX) has an overall rating of Buy, with a price target of 63.07.
What is the Earnings Per Share (EPS TTM) of Celldex Therapeutics Inc (CLDX)?
The Earnings Per Share (EPS TTM) of Celldex Therapeutics Inc (CLDX) is -4.27.